Enterprise Value
259.8M
Cash
115.2M
Avg Qtr Burn
-16.97M
Short % of Float
10.75%
Insider Ownership
2.34%
Institutional Own.
88.33%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
BDTX-1535 Details Cancer, Non-small cell lung carcinoma | Phase 2 Data readout | |
BDTX-1535 Details Non-small cell lung carcinoma, Cancer | Phase 2 Data readout | |
BDTX-1535 Details Cancer, Glioblastoma | Phase 1 Data readout | |
BDTX-4933 Details Cancer | Phase 1 Update | |
BDTX-189 (EGFR HER2) Details Solid tumor/s, Cancer | Failed Discontinued |